Drug Shortage Report for AURO-REPAGLINIDE

Last updated on 2024-02-13 History
Report ID 219319
Drug Identification Number 02424266
Brand name AURO-REPAGLINIDE
Common or Proper name AURO-REPAGLINIDE
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) REPAGLINIDE
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100's
ATC code A10BX
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-02-12
Estimated end date 2024-03-29
Actual end date
Shortage status Actual shortage
Updated date 2024-02-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-02-13 English Compare
v2 2024-02-12 French Compare
v1 2024-02-12 English Compare

Showing 1 to 3 of 3